Market Scenario
Moebius syndrome is a rare neurological condition characterized by paralysis of multiple cranial nerves, and most often the abducens and facial nerves. Signs and symptoms of Moebius include paralysis of the facial muscles, swallowing and choking problems, crossed eyes, bone abnormalities in the hands, speech difficulties, high or cleft palate, excessive drooling, and various others. As per the National Center for Advancing Translational Sciences, abnormality of the voice, masklike facies, Bell's palsy, feeding difficulties in infancy, and open mouth commonly occur in 80%-99% cases of Moebius syndrome.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5407
According to the U.S National Library of Medicine, Moebius syndrome affects 1 in 50,000 to 1 in 500,000 newborns. It also mentions that the affected individuals lack facial expressions i.e. they cannot smile, or raise their eyebrows.
It is noted that growing public awareness and technological advancements are the key factors driving the Moebius syndrome treatment market. On the technology front, various surgical options have been used for an effective management of symptoms associated with Moebius syndrome such as facial nerve grafting, facial nerve decompression, transposition of the temporalis muscle, and others.
Various other factors such as unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising funding and reimbursement policies are continuously contributing to the growth of the global Moebius syndrome market. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and the hospital care accounted for a share of 32.3%.
Despite these drivers, there are some issues associated with Moebius syndrome market. The complications associated with the available treatments, infections, and injuries caused by surgical devices, and poor healthcare system in low and middle-income countries, may hinder the growth of the market.
It is estimated that the Moebius syndrome market is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023.
Key Players
Some of key the players in the global moebius syndrome market are Alcon Laboratories, Inc, All Vascular, Pty Ltd., Aspen Surgical Products, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Conmed Corporation, Gray Surgical, Johnson & Johnson Services, Inc., Medtronic, Olympus Corporation, Smith & Nephew plc, TransEnterix Surgical, Inc., Zimmer Biomet Holdings, Inc., and others.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/moebius-syndrome-market-5407
Global Ligation Devices Market Report: By Product (Handheld Instruments, Accessories), Procedure (Minimally Invasive Surgery, Open Surgery), and Application (Gastrointestinal and Abdominal, Gynecological, Urological Applications)—Global Forecast till 2024 Market HighlightsLigation devices are used during surgeries for closing incisions or to join separated organs/tissue parts.
According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year.
However, the high cost of surgery and related side effects are estimated to restraint the market growth.The global ligation devices market trends is expected to register a CAGR of 6.7% during the forecast period of 2019 to 2024.Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7794 Regional AnalysisThe Americas dominated the global ligation devices market in 2018.
Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.Asia-Pacific was the fastest growing region for the global ligation devices market in 2018.
According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.On the other hand, the Middle East and Africa held the least share in the global ligation devices market.
Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.Key PlayersSome of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.SegmentationThe global ligation devices market is segmented based on product, procedure, application, end user, and region.On the basis of product, the market is segmented into handheld instruments and accessories.
According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year.
However, the high cost of surgery and related side effects are estimated to restraint the market growth.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7794SegmentationThe global ligation devices market is segmented based on product, procedure, application, end user, and region.On the basis of product, the market is segmented into handheld instruments and accessories.
Based on procedure, the market is segmented into minimally invasive surgery and open surgery.
The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others.
Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.Regional AnalysisThe Americas dominated the global ligation devices market in 2018.
Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries.
Global Ligation Devices Market Report: By Product (Handheld Instruments, Accessories), Procedure (Minimally Invasive Surgery, Open Surgery), and Application (Gastrointestinal and Abdominal, Gynecological, Urological Applications)—Global Forecast till 2027As per Market Research Future (MRFR) analysis, the global ligation devices market is estimated to register a CAGR of 6.7% from 2019 to 2024 (forecast period).Ligation devices are used for closing incisions during surgeries or for connecting separate organ/tissue parts.
The number of surgeries and laparoscopic procedures has increased in the last few years.
According to the 2017 National Health Statistics Reports published by the Centers for Disease Control and Prevention, 48.3 million surgical/non-surgical procedures were performed in the United States in 2010.
As per the GI Endoscopy Coding and Reimbursement Guide published by Cook in 2017, procedures such as endoscopic retrograde cholangiopancreatography (ERCP) are covered by CPT code 43261 with an average facility payment of approximately USD 1.134.02.However, it is projected that factors such as the high cost of surgery and related side effects would hinder the market growth.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7794SegmentationThe global market for ligation devices has been segmented based on the product, procedure, application, end-user, and region.Based on product, the global market for ligation devices has been segmented into handheld instruments and accessories.Based on the procedure, the global market for ligation devices has been segmented into minimally invasive surgery and open surgery.Based on application, the global market for ligation devices has been segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others.Based on the end-user, the global market for ligation devices has been segmented into hospitals & clinics, ambulatory surgical center, and others.Regional AnalysisRegionally, the global ligation devices market has been segmented into the Americas, Asia Pacific, Europe, the Middle East & Africa.The Americas held the largest market share for ligation devices due to rising health expenditure and the growing prevalence of chronic diseases.
As reported by the Centers for Disease Control and Prevention in 2018, coronary heart disease (CHD) has been estimated to be the most common type of heart disease in the U.S. and is expected to cause 370,000 heart disease per year.Europe held the second position in the global market for ligation devices in 2018.
It can be due to growing awareness, government funding, the production of technologically advanced medical devices, and the rising number of surgeries.
Spina Bifida Market Research Report: By Type (Occulta, Closed Neural Tube Defects, Meningocele, Myelomeningocele), By Diagnosis (Blood Test, Ultrasound, Amniocentesis), Treatment (Medical Procedure, Surgeries), By End User – Global Forecast Till 2023Market Highlights:Spina bifida is a neural tube defect in which a group of cells that develops into the spinal cord and brain, fails to close completely during embryonic development.A number of factors such as increasing technological advancements, rising awareness, increased incidence of spina bifida, related complications, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate, and improvement in funding and reimbursement policies are few factors propelling the growth of the global spina bifida market.Intended AudiencePharmaceutical CompaniesMedical Device CompaniesResearch and Development (R) CompaniesDiagnostic LaboratoriesGovernment Research InstituteAcademic Institutes and UniversitiesAvail a Free Sample@ https://www.marketresearchfuture.com/sample_request/5643However, cost of treatment, side-effects of surgeries, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the review period.It is estimated that the spina bifida market is expected to grow at a CAGR 8.0% during the forecast period of 2017-2023.Regional Analysis:The Americas dominate the spina bifida market owing to the rising occurrence of spina bifida in this region, and technological advancements.
According to the statistics suggested by Centers for Disease Control and Prevention (CDC), around 1,500 babies are born with spina bifida every year in the United States.
It is expected that the government support towards research & development expenditure, and amendments in reimbursement policies in the healthcare is likely to drive the European spina bifida market.Asia Pacific is the fastest growing spina bifida market owing to a huge patient pool and continuous developments in healthcare technology.
According to the data suggested by the Australian Institute of Health and Welfare, during the year 2015-16, the total health expenditure was USD 170.4 billion i.e.
3.6% higher than the expenditure of 2014-2015.The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.Segmentation:The global spina bifida market is segmented on the basis of type, diagnosis, treatment, and end user.On the basis of the type, the market is classified as occulta, closed neural tube defects, meningocele, and myelomeningocele.On the basis of the diagnosis, the market is classified as blood tests, ultrasound, amniocentesis, and others.
The medical procedure is further segmented into urinary catheterization, urinary diversion, and enema.
Orthobiologics are derived from the human body and used by surgeons for treating injuries.
It helps in easy recovery and healing of wounds.
The surge in cases of trauma and sports injury, rising demand for biologics in minimally invasive procedures, increasing product approvals, and raising awareness are expected to drive the growth of the global orthobiologics market during the forecast period.Moreover, emerging technological inventions in biomaterials, growing obese and geriatric population, and increasing research and development activities by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market.
According to the report published by the Centers for Disease Control and Prevention (CDC), in 2016, 5.1% of men of 65 years and over are suffering from the lumbar spine in the US.
Also, 24.5% of women 65 years of age and over have a lumbar spine in US.The high costs associated with the orthobiologics, absence of proper reimbursement policies and scarcity of skilled workforce may hamper the growth of the market during the assessment period.Global Orthobiologics Market: Competitive LandscapeSome of the key players in the global Orthobiologics Market areArthrex, Inc.Exactech, Inc.Globus Medical Inc.Integra LifeSciencesJohnson & JohnsonMedline Industries, Inc.NuVasive, Inc.Stryker CorporationWright Medical Group N.V.Zimmer BiometOrthobiologics Market SegmentationThe global orthobiologics market has been segmented on the basis of product, application, end-user, and region.Based on product, the market has been classified as a Demineralized bone matrix (DBM), Bone morphogenetic protein (BPM), Allograft, Viscosupplementation products, Synthetic bone substitutes, and Others.Global orthobiologics market on the basis of application has been segmented into Osteoarthritis & degenerative arthritis, Spinal fusion, Fracture recovery, Soft tissue injuries, and Others.Based on end-user, the market has been segmented into Hospitals, Orthopedic Clinics, and Others.Orthobiologics Market Regional AnalysisThe market is likely to dominate by Americas during the forecast period owing to the well-established healthcare infrastructure, rising incidences of spinal disorders, obese and geriatric population, and preference for minimally invasive procedures.Europe is expected to be the second-largest market in the global orthobiologics market due to the rising adoption of newly introduced treatment procedures and technologies by a physician and patient awareness, government funding and support of the healthcare sector.The Asia-Pacific market is likely to hold a significant market share in the orthobiologics market.
The rising demand for advanced treatment, awareness and increasing investment in healthcare are responsible for the growth of this market in the region.The market in the Middle East & Africa is expected to account for the smallest share of the global orthobiologics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.Table Of Content1.
It helps in easy recovery and healing of wounds.
The surge in cases of trauma and sports injury, rising demand for biologics in minimally invasive procedures, increasing product approvals, and raising awareness are expected to drive the growth of the global orthobiologics market during the forecast period.Moreover, emerging technological inventions in biomaterials, growing obese and geriatric population, and increasing research and development activities by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market.
According to the report published by the Centers for Disease Control and Prevention (CDC), in 2016, 5.1% of men of 65 years and over are suffering from the lumbar spine in the US.
Also, 24.5% of women 65 years of age and over have a lumbar spine in US.The high costs associated with the orthobiologics, absence of proper reimbursement policies and scarcity of skilled workforce may hamper the growth of the market during the assessment period.Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7826Global Orthobiologics Market - Segmentations The global orthobiologics market has been segmented on the basis of product, application, end-user, and region.Based on product, the market has been classified as a Demineralized bone matrix (DBM), Bone morphogenetic protein (BPM), Allograft, Viscosupplementation products, Synthetic bone substitutes, and Others.Global orthobiologics market on the basis of application has been segmented into Osteoarthritis & degenerative arthritis, Spinal fusion, Fracture recovery, Soft tissue injuries, and Others.Based on end-user, the market has been segmented into Hospitals, Orthopedic Clinics, and Others.Global Orthobiologics Market - Geographical AnalysisNorth America dominates the global orthobiologics market, owing to the technological advancements, increasing funding & investments, and rising prevalence of bone injuries caused due to accidents.
The availability of innovative treatment facilities alongside, the rising research initiatives in the field of orthopedic biomaterials is fostering the market growth in the region.
Besides, the improved economy in the region drives the growth of the orthobiologics market, colossally, creating various growth opportunities.Global Orthobiologics Market - Competitive Landscape Highly competitive, the orthobiologics market appears to be fragmented due to the presence of several well-established players.
